Abstract

Budesonide 1-mg//10-mL Mucolox Oral Suspensions

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 317

Download in electronic PDF format for $75

Abstract

A formulation for preparing Budesonide 1-mg//10-mL Mucolox Oral Suspensions. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2017 Pg. 322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 254-261	Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 287-290	Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Author(s): Reisacher William, Rudner Shara, Kotik Viktoriya
Jul/Aug 2012 Pg. 288-293	Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Author(s): Zur Eyal
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 155-158	Utilization of Compounded Medications in an Oral Medicine Practice Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Jan/Feb 2007 Pg. 72	Dexamethasone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 340-346	Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jan/Feb 2007 Pg. 77	Prednisone 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 78	Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 242	Celecoxib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr